| Date | Time | Source | Headline | Symbol | Company |
| 06/01/2009 | 8:30AM | PR Newswire (US) | Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study | NASDAQ:AEZS | |
| 06/01/2009 | 7:00AM | PR Newswire (US) | AEterna Zentaris Presents Data Supporting Evaluation of AEZS-108 in Prostate Cancer at ASCO Meeting | NASDAQ:AEZS | |
| 05/19/2009 | 7:00AM | PR Newswire (US) | AEterna Zentaris to Present Data Supporting Evaluation of AEZS-108 in Prostate Cancer at Upcoming ASCO Meeting | NASDAQ:AEZS | |
| 05/07/2009 | 2:12PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 05/07/2009 | 2:11PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 05/06/2009 | 7:00AM | PR Newswire (US) | AEterna Zentaris Reports First Quarter 2009 Financial and Operating Results | NASDAQ:AEZS | |
| 04/30/2009 | 7:00AM | PR Newswire (US) | AEterna Zentaris to Announce First Quarter 2009 Financial and Operating Results and Hold Annual Shareholder Meeting on May 6, 20 | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 04/29/2009 | 7:00AM | PR Newswire (US) | AEterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | NASDAQ:AEZS | |
| 04/22/2009 | 10:00AM | PR Newswire (US) | AEterna Zentaris Presents Phase 1 Results for AEZS-112 in Patients with Advanced Cancer and Lymphoma at AACR Annual Meeting in D | NASDAQ:AEZS | |
| 04/21/2009 | 10:00AM | PR Newswire (US) | AEterna Zentaris Presents Two Posters on its PI3K Inhibitor Compound, AEZS-126, at AACR Annual Meeting | NASDAQ:AEZS | |
| 04/15/2009 | 7:30AM | PR Newswire (US) | AEterna Zentaris To Present Data on Anticancer Compounds AEZS-112 and AEZS-126 at AACR Annual Meeting | NASDAQ:AEZS | |
| 04/07/2009 | 6:01AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 03/30/2009 | 3:20PM | Edgar (US Regulatory) | Annual and Transition Report (foreign private issuer) (20-F) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 03/17/2009 | 4:52PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 03/12/2009 | 3:18PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 03/11/2009 | 4:23PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 03/11/2009 | 6:51AM | PR Newswire (US) | AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 03/09/2009 | 11:28AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 03/06/2009 | 3:49PM | PR Newswire (US) | AEterna Zentaris to Announce Fourth Quarter and Full-Year 2008 Financial and Operating Results on March 11, 2009 | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 03/06/2009 | 7:00AM | PR Newswire (US) | AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prost | NASDAQ:AEZS | |
| 02/26/2009 | 8:29AM | PR Newswire (US) | Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexam | NASDAQ:AEZS | |
| 02/17/2009 | 7:32AM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 12/11/2008 | 11:26AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 12/11/2008 | 7:30AM | PR Newswire (US) | AEterna Zentaris Completes Patient Recruitment for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplas | NASDAQ:AEZS | |
| 12/09/2008 | 11:47AM | PR Newswire (US) | Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hem | NASDAQ:AEZS | |
| 12/04/2008 | 7:30AM | PR Newswire (US) | AEterna Zentaris to Present at Upcoming RBC Capital Markets Healthcare Conference | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 12/03/2008 | 3:52PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 12/03/2008 | 7:30AM | PR Newswire (US) | AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners | NASDAQ:AEZS | |
| 11/24/2008 | 11:14AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/13/2008 | 4:30PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |